Healthcare provider profile · identity verified

Wayne Mcwilliams, MD

Internal Medicine · BETHLEHEM, PA · NPI 1316998651

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1043	291
Amlodipine Besylate	Amlodipine Besylate	860	250
Lisinopril	Lisinopril	786	215
Levothyroxine Sodium	Levothyroxine Sodium	730	168
Losartan Potassium	Losartan Potassium	515	148
Omeprazole	Omeprazole	345	92
Pantoprazole Sodium	Pantoprazole Sodium	307	108
Alprazolam	Alprazolam	297	71
Simvastatin	Simvastatin	296	77
Hydrochlorothiazide	Hydrochlorothiazide	295	94
Metformin Hcl	Metformin Hcl	279	78
Metoprolol Succinate	Metoprolol Succinate	266	82
Gabapentin	Gabapentin	263	73
Rosuvastatin Calcium	Rosuvastatin Calcium	226	60
Metoprolol Tartrate	Metoprolol Tartrate	194	52
Eliquis	Apixaban	186	43
Sertraline Hcl	Sertraline Hcl	168	56
Furosemide	Furosemide	137	43
Allopurinol	Allopurinol	130	43
Tamsulosin Hcl	Tamsulosin Hcl	127	46
Albuterol Sulfate Hfa	Albuterol Sulfate	121	38
Lorazepam	Lorazepam	118	33
Fluticasone Propionate	Fluticasone Propionate	117	41
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	116	22
Famotidine	Famotidine	103	28
Citalopram Hbr	Citalopram Hydrobromide	88	27
Trazodone Hcl	Trazodone Hcl	85	24
Celecoxib	Celecoxib	84	25
Potassium Chloride	Potassium Chloride	83	22
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	80	22
Mirtazapine	Mirtazapine	77	26
Clonazepam	Clonazepam	74	12
Atenolol	Atenolol	71	20
Clopidogrel	Clopidogrel Bisulfate	70	19
Escitalopram Oxalate	Escitalopram Oxalate	68	16
Jardiance	Empagliflozin	68	20
Montelukast Sodium	Montelukast Sodium	68	21
Spironolactone	Spironolactone	68	21
Glimepiride	Glimepiride	66	21
Synthroid	Levothyroxine Sodium	64	16
Tramadol Hcl	Tramadol Hcl	62	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	61	18
Carvedilol	Carvedilol	60	20
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	59	suppressed
Methocarbamol	Methocarbamol	58	18
Triamcinolone Acetonide	Triamcinolone Acetonide	58	24
Duloxetine Hcl	Duloxetine Hcl	55	14
Pravastatin Sodium	Pravastatin Sodium	55	14
Pregabalin	Pregabalin	55	suppressed
Diclofenac Sodium	Diclofenac Sodium	54	13
Ezetimibe	Ezetimibe	53	18
Meloxicam	Meloxicam	52	15
Venlafaxine Hcl Er	Venlafaxine Hcl	51	15
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	49	13
Warfarin Sodium	Warfarin Sodium	49	11
Valsartan	Valsartan	47	14
Alendronate Sodium	Alendronate Sodium	43	16
Buspirone Hcl	Buspirone Hcl	43	14
Levetiracetam	Levetiracetam	43	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	40	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	40	11
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	39	12
Enalapril Maleate	Enalapril Maleate	39	11
Tradjenta	Linagliptin	39	suppressed
Xarelto	Rivaroxaban	38	16
Fluoxetine Hcl	Fluoxetine Hcl	35	suppressed
Baclofen	Baclofen	34	suppressed
Metformin Hcl Er	Metformin Hcl	33	13
Quetiapine Fumarate	Quetiapine Fumarate	33	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	32	12
Fenofibrate	Fenofibrate Nanocrystallized	31	suppressed
Diazepam	Diazepam	30	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	30	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	29	suppressed
Finasteride	Finasteride	27	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	27	suppressed
Meclizine Hcl	Meclizine Hcl	26	16
Ozempic	Semaglutide	26	suppressed
Lamotrigine	Lamotrigine	25	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	25	suppressed
Temazepam	Temazepam	24	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	23	suppressed
Naproxen	Naproxen	23	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	23	suppressed
Azelastine Hcl	Azelastine Hcl	22	suppressed
Ramipril	Ramipril	22	suppressed
Entresto	Sacubitril/Valsartan	21	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	21	suppressed
Ventolin Hfa	Albuterol Sulfate	21	suppressed
Ibuprofen	Ibuprofen	20	suppressed
Bupropion Xl	Bupropion Hcl	19	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	19	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	19	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	18	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	18	suppressed
Bupropion Hcl Sr	Bupropion Hcl	18	suppressed
Ipratropium Bromide	Ipratropium Bromide	18	suppressed
Mitigare	Colchicine	18	suppressed
Topiramate	Topiramate	18	suppressed
Breo Ellipta	Fluticasone/Vilanterol	17	suppressed
Januvia	Sitagliptin Phosphate	17	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	17	suppressed
Solifenacin Succinate	Solifenacin Succinate	17	suppressed
Trulicity	Dulaglutide	17	suppressed
Valacyclovir	Valacyclovir Hcl	17	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	16	suppressed
Colchicine	Colchicine	16	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	16	suppressed
Linzess	Linaclotide	16	suppressed
Chlorthalidone	Chlorthalidone	15	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	15	suppressed
Ketoconazole	Ketoconazole	15	suppressed
Klor-Con M20	Potassium Chloride	15	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	15	suppressed
Torsemide	Torsemide	15	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	14	14
Ciclopirox	Ciclopirox Olamine	14	suppressed
Lansoprazole	Lansoprazole	14	suppressed
Spiriva Respimat	Tiotropium Bromide	14	suppressed
Verapamil Er	Verapamil Hcl	14	suppressed
Amiodarone Hcl	Amiodarone Hcl	13	suppressed
Benazepril Hcl	Benazepril Hcl	13	suppressed
Calcitriol	Calcitriol	13	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	13	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	13	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	13	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	13	suppressed
Lactulose	Lactulose	13	suppressed
Sucralfate	Sucralfate	13	suppressed
Trihexyphenidyl Hcl	Trihexyphenidyl Hcl	13	suppressed
Trospium Chloride	Trospium Chloride	13	suppressed
Azithromycin	Azithromycin	12	suppressed
Bicalutamide	Bicalutamide	12	suppressed
Donepezil Hcl	Donepezil Hcl	12	suppressed
Fenofibrate	Fenofibrate,micronized	12	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	12	suppressed
Levemir Flexpen	Insulin Detemir	12	suppressed
Lubiprostone	Lubiprostone	12	suppressed
Methylprednisolone	Methylprednisolone	12	12
Nadolol	Nadolol	12	suppressed
Nifedipine Er	Nifedipine	12	suppressed
Nystatin	Nystatin	12	suppressed
Paroxetine Hcl	Paroxetine Hcl	12	suppressed
Ropinirole Hcl	Ropinirole Hcl	12	suppressed
Tresiba Flextouch U-100	Insulin Degludec	12	suppressed
Amoxicillin	Amoxicillin	11	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	11	suppressed
Fenofibrate	Fenofibrate	11	suppressed
Humalog Kwikpen U-100	Insulin Lispro	11	suppressed
Metformin Er Gastric	Metformin Hcl	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	suppressed
Symbicort	Budesonide/Formoterol Fumarate	11	suppressed
Tizanidine Hcl	Tizanidine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error